FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291366447> ?p ?o ?g. }

• W4291366447 endingPage "3911" @default.
• W4291366447 startingPage "3911" @default.
• W4291366447 abstract "Endometrial cancer (EC) is one of the most common malignancies of the female genital tract and its current treatment mainly relies on surgical removal of the tumour bulk, followed by adjuvant radiotherapy with or without chemotherapy/hormonal therapy. However, the outcomes of these approaches are often unsatisfactory and are associated with severe toxicity and a higher recurrence rate of the disease. Thus, more clinical research exploring novel medical intervention is needed. Involvement of the immune pathway in cancer has become important and the finding of a high positive expression of programmed cell death-ligand 1 (PD-L1) in EC may offer a better targeted therapeutic approach. Numerous studies on the PD-L1 role in EC have been conducted, but the results remained inconclusive. Hence, this systematic review was conducted to provide an update and robust analysis in order to determine the pooled prevalence of PD-L1 expression in EC and evaluate its association with clinicopathological features in different focuses of tumour cells (TC) and immune cells (IC). A comprehensive literature search was conducted using the PubMed, Web of Science, and Scopus databases. Twelve articles between 2016 and 2021 with 3023 EC cases met the inclusion criteria. The effect of PD-L1 expression on the outcome parameters was estimated by the odds ratios (ORs) with 95% confidence intervals (CIs) for each study. The pooled prevalence of PD-L1 was 34.26% and 51.39% in the tumour cell and immune cell, respectively, among women with EC. The PD-L1 expression was significantly associated with Stage III/IV disease (in both TC and IC) and correlated to the presence of lympho-vascular invasion in IC. However, the PD-L1 expression in TC was not associated with the age groups, histology types, myometrial invasion, and lympho-vascular invasion. In IC, PD-L1 expression was not associated with age group, histology type, and myometrial invasion. The meta-analysis survival outcomes of PD-L1 high expression had a significant association with worse OS in IC but not in TC." @default.
• W4291366447 created "2022-08-15" @default.
• W4291366447 creator A5006465517 @default.
• W4291366447 creator A5029657020 @default.
• W4291366447 creator A5039296343 @default.
• W4291366447 creator A5052879796 @default.
• W4291366447 creator A5054053029 @default.
• W4291366447 creator A5054280394 @default.
• W4291366447 creator A5066156540 @default.
• W4291366447 date "2022-08-13" @default.
• W4291366447 modified "2023-10-14" @default.
• W4291366447 title "PD-L1 Expression in Endometrial Cancer and Its Association with Clinicopathological Features: A Systematic Review and Meta-Analysis" @default.
• W4291366447 cites W1966756094 @default.
• W4291366447 cites W1990675339 @default.
• W4291366447 cites W1996863944 @default.
• W4291366447 cites W2049553585 @default.
• W4291366447 cites W2088270805 @default.
• W4291366447 cites W2092921437 @default.
• W4291366447 cites W2116475791 @default.
• W4291366447 cites W2118982164 @default.
• W4291366447 cites W2143772132 @default.
• W4291366447 cites W2156098321 @default.
• W4291366447 cites W2161937716 @default.
• W4291366447 cites W2405345993 @default.
• W4291366447 cites W2420990297 @default.
• W4291366447 cites W2509481886 @default.
• W4291366447 cites W2532858212 @default.
• W4291366447 cites W2559826815 @default.
• W4291366447 cites W2560367415 @default.
• W4291366447 cites W2572174216 @default.
• W4291366447 cites W2578528809 @default.
• W4291366447 cites W2592133876 @default.
• W4291366447 cites W2592666036 @default.
• W4291366447 cites W2599604693 @default.
• W4291366447 cites W2606764737 @default.
• W4291366447 cites W2747016053 @default.
• W4291366447 cites W2750443108 @default.
• W4291366447 cites W2765706188 @default.
• W4291366447 cites W2767183168 @default.
• W4291366447 cites W2772391116 @default.
• W4291366447 cites W2777880635 @default.
• W4291366447 cites W2781525129 @default.
• W4291366447 cites W2790574591 @default.
• W4291366447 cites W2790603825 @default.
• W4291366447 cites W2794577178 @default.
• W4291366447 cites W2794764434 @default.
• W4291366447 cites W2799811063 @default.
• W4291366447 cites W2809724091 @default.
• W4291366447 cites W2883840395 @default.
• W4291366447 cites W2886987811 @default.
• W4291366447 cites W2888337953 @default.
• W4291366447 cites W2890371056 @default.
• W4291366447 cites W2895006950 @default.
• W4291366447 cites W2895123463 @default.
• W4291366447 cites W2904019899 @default.
• W4291366447 cites W2906691968 @default.
• W4291366447 cites W2909460006 @default.
• W4291366447 cites W2932312422 @default.
• W4291366447 cites W2951038296 @default.
• W4291366447 cites W2978515184 @default.
• W4291366447 cites W2981339276 @default.
• W4291366447 cites W2987385271 @default.
• W4291366447 cites W2991792334 @default.
• W4291366447 cites W3001054666 @default.
• W4291366447 cites W3001990555 @default.
• W4291366447 cites W3009533514 @default.
• W4291366447 cites W3011919019 @default.
• W4291366447 cites W3015178699 @default.
• W4291366447 cites W3021824476 @default.
• W4291366447 cites W3028556187 @default.
• W4291366447 cites W3030448313 @default.
• W4291366447 cites W3034775800 @default.
• W4291366447 cites W3038130564 @default.
• W4291366447 cites W3046756565 @default.
• W4291366447 cites W3122084587 @default.
• W4291366447 cites W3128646645 @default.
• W4291366447 cites W3134181111 @default.
• W4291366447 cites W3135936453 @default.
• W4291366447 cites W3181861767 @default.
• W4291366447 cites W3197135041 @default.
• W4291366447 cites W4210676785 @default.
• W4291366447 cites W4210989197 @default.
• W4291366447 doi "https://doi.org/10.3390/cancers14163911" @default.
• W4291366447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36010904" @default.
• W4291366447 hasPublicationYear "2022" @default.
• W4291366447 type Work @default.
• W4291366447 citedByCount "10" @default.
• W4291366447 countsByYear W42913664472022 @default.
• W4291366447 countsByYear W42913664472023 @default.
• W4291366447 crossrefType "journal-article" @default.
• W4291366447 hasAuthorship W4291366447A5006465517 @default.
• W4291366447 hasAuthorship W4291366447A5029657020 @default.
• W4291366447 hasAuthorship W4291366447A5039296343 @default.
• W4291366447 hasAuthorship W4291366447A5052879796 @default.
• W4291366447 hasAuthorship W4291366447A5054053029 @default.
• W4291366447 hasAuthorship W4291366447A5054280394 @default.
• W4291366447 hasAuthorship W4291366447A5066156540 @default.
• W4291366447 hasBestOaLocation W42913664471 @default.

• next